104 related articles for article (PubMed ID: 862425)
1. Effect of intramuscular triamcinolone acetonide on the human ovulatory cycle.
Carson TE; Daane TA; Lee PA; Tredway DR; Wallin JD
Cutis; 1977 May; 19(5):633-7. PubMed ID: 862425
[TBL] [Abstract][Full Text] [Related]
2. Antiovulatory activity of synthetic corticoids.
Cunningham GR; Caperton EM; Goldzieher JW
J Clin Endocrinol Metab; 1975 Feb; 40(2):265-7. PubMed ID: 1117979
[TBL] [Abstract][Full Text] [Related]
3. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
[TBL] [Abstract][Full Text] [Related]
4. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
Fogel M; Rubin BL; Ossowski R
Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
[TBL] [Abstract][Full Text] [Related]
5. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
[TBL] [Abstract][Full Text] [Related]
6. Some aspects on pituitary function in human and rat anovulatory cycles.
Makino T; Shiina M; Ohno T; Iizuka R; Tamaoki B
Endocrinol Jpn; 1976 Dec; 23(6):445-9. PubMed ID: 798684
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
[TBL] [Abstract][Full Text] [Related]
8. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
Balogh A; Ditrói F; Lampé LG
Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
[TBL] [Abstract][Full Text] [Related]
9. Ovulation inhibition by daily i.m. administration of a highly active LH-RH analog (d-ser(TBU)6-LH-RH-(1-9)-nonapeptide-ethylamide).
Baumann R; Kuhl H; Taubert HD; Sandow J
Contraception; 1980 Feb; 21(2):191-7. PubMed ID: 6768492
[TBL] [Abstract][Full Text] [Related]
10. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)].
Netter A; Gorins A; Thomas K; Cohen M; Joubinaux J
Ann Endocrinol (Paris); 1973; 34(4):430-5. PubMed ID: 4779738
[TBL] [Abstract][Full Text] [Related]
11. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
[TBL] [Abstract][Full Text] [Related]
12. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Lemay A; Faure N
J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
[TBL] [Abstract][Full Text] [Related]
13. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
[TBL] [Abstract][Full Text] [Related]
14. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
Baird DT; McNeilly AS; Sawers RS; Sharpe RM
J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
[TBL] [Abstract][Full Text] [Related]
15. Pituitary and ovarian response to acute stimulation with LH-RH in normal and anovulatory women.
Aparicio NJ; Casas PR; Galimberti DM; de Laborde NP; Badano A; García EP; Meichi HR; Mirkin A; Szejner M; Jaitt A; Margulies M; Rosner JM
Int J Fertil; 1977; 22(1):6-15. PubMed ID: 18416
[TBL] [Abstract][Full Text] [Related]
16. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
[TBL] [Abstract][Full Text] [Related]
17. Monitoring of ovulation induction.
Wu CH
Fertil Steril; 1978 Dec; 30(6):617-30. PubMed ID: 729822
[TBL] [Abstract][Full Text] [Related]
18. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of ovulation inhibition by triamcinolone acetonide.
Cunningham GR; Goldzieher JW; de la Pena A; Oliver M
J Clin Endocrinol Metab; 1978 Jan; 46(1):8-14. PubMed ID: 376542
[TBL] [Abstract][Full Text] [Related]
20. Response to intermittent RU486 in women.
Spitz IM; Croxatto HB; Salvatierra AM; Heikinheimo O
Fertil Steril; 1993 May; 59(5):971-5. PubMed ID: 8486197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
